Theratechnologies Inc. (THTX)
NASDAQ: THTX · IEX Real-Time Price · USD
1.560
+0.020 (1.30%)
At close: Jul 19, 2024, 4:00 PM
1.660
+0.100 (6.41%)
Pre-market: Jul 22, 2024, 7:42 AM EDT
Theratechnologies Stock Forecast
THTX's stock price has decreased by -50.88% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Theratechnologies stock has a target of 12, which predicts an increase of 669.23% from the current stock price of 1.56.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 17, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for THTX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JonesTrading | JonesTrading | Strong Buy Maintains $24 → $12 | Strong Buy | Maintains | $24 → $12 | +669.23% | Jul 17, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $36 | Buy | Reiterates | $36 | +2,207.69% | Jul 13, 2023 |
Canaccord Genuity | Canaccord Genuity | Hold Initiates $8 | Hold | Initiates | $8 | +412.82% | Jul 3, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $36 | Buy | Initiates | $36 | +2,207.69% | Nov 17, 2022 |
Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 29, 2021 |
Financial Forecast
Revenue This Year
90.52M
from 81.76M
Increased by 10.71%
Revenue Next Year
102.05M
from 90.52M
Increased by 12.74%
EPS This Year
-0.01
from -0.91
EPS Next Year
0.15
from -0.01
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 94.5M | 112.9M | 145.7M | 239.2M | 388.0M |
Avg | 90.5M | 102.1M | 119.9M | 143.8M | 186.1M |
Low | 85.4M | 90.3M | 95.3M | 96.1M | 100.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 15.6% | 24.8% | 42.8% | 99.4% | 169.8% |
Avg | 10.7% | 12.7% | 17.5% | 19.9% | 29.4% |
Low | 4.4% | -0.2% | -6.7% | -19.8% | -30.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.04 | 0.28 | 0.82 | 2.09 | 4.11 |
Avg | -0.01 | 0.15 | 0.41 | 0.86 | 1.57 |
Low | -0.04 | 0.03 | 0.14 | 0.19 | 0.27 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 430.1% | 406.7% | 375.5% |
Avg | - | - | 166.7% | 109.9% | 82.1% |
Low | - | - | -11.2% | -54.6% | -69.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.